tr004
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2018 (NCT03185000)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- regulatory t cellsSupplementation
regulatory t cells supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tr004
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03185000 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2018 | Medical Research Council, Miltenyi Biotec, Inc., University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medical Research Council | Government | 1 | 0 | 1 | 2018 |
| Miltenyi Biotec, Inc. | For profit | 1 | 0 | 1 | 2018 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1